| Leah Brecher-cohn, LMFT | |
|
10 E Athens Ave, Suite 202a, Ardmore, PA 19003-2115 | |
| (610) 246-3381 | |
| (610) 246-3381 |
| Full Name | Leah Brecher-cohn |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 10 E Athens Ave, Ardmore, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578985891 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | MF000443 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Leah Brecher-cohn, LMFT 1315 Drayton Ln, Wynnewood, PA 19096-3310 Ph: (610) 246-3381 | Leah Brecher-cohn, LMFT 10 E Athens Ave, Suite 202a, Ardmore, PA 19003-2115 Ph: (610) 246-3381 |
News Archive
The Magnetic Resonance Center of the University Children's Hospital Zurich has achieved a world first break through in MR-guided, non-invasive neurosurgery. Ten patients have been successfully treated by means of transcranial high-intensity focused ultrasound. This fully non-invasive procedure opens new horizons for neurosurgery and the treatment of different neurological brain disorders.
The emergence of drug-resistant strains of HIV could one day threaten efforts to control the global HIV pandemic, according to a study published online Thursday in the journal Science, HealthDay News/U.S. News & World Report reports. The researchers based their findings on "a mathematical model that tracks the transmission of multiple strains of HIV" in San Francisco, the news service writes (1/14).
Pulmatrix, Inc., a clinical stage biotechnology company creating novel inhaled therapeutics, announced today that three posters on its lead iCALM therapeutic, the first treatment developed utilizing its iSPERSE inhaled drug platform, will be presented at the European Respiratory Society (ERS) Annual Congress taking place September 1-5, 2012, in Vienna, Austria.
Ascletis today announced it received the approval from the Taiwan Food and Drug Administration (TFDA) to start phase II clinical trial for its all-oral interferon (IFN)-free regimen to treat chronic hepatitis C (CHC).
› Verified 7 days ago
Mr. William Edward Mayer, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 17 Llanfair Road, Suite 107, Ardmore, PA 19003 Phone: 610-368-0392 | |
Mrs. Karni Kissil, M.A., M.ED Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1906 Chestnut Cir, Ardmore, PA 19003 Phone: 610-715-1528 | |
Ms. Arlene Barbara Kramer, LCSW,ACSW,BCD Couples Therapy Medicare: Accepting Medicare Assignments Practice Location: 700 Ardmore Ave, #217, Ardmore, PA 19003 Phone: 610-649-3637 Fax: 610-649-7899 |